Join us on June 25th for a webinar on Phenotypic Disease Modeling for Inflammation by Lenie van den Broek of MIMETAS! Learn about 3D disease modeling's impact on drug discovery. Register now: bit.ly/3zilFO4 #Inflammation #ImmuneTherapies

⏰ Last day to register for our live webinar! Tomorrow, our Director of Biology, Lenie van den Broek will share insights on phenotypic disease modeling for inflammation and advancing the discovery of immune-targeting therapies. Register here: bit.ly/4c0dSmA

Snapshots from #FENS2024, Europe's largest neuroscience congress! Our scientist Nienke Wevers presented the latest advancements MIMETAS is making in understanding the complexities of the BBB and neuroinflammation. Download our BBB app note to learn more: mimetas.com/en/app-notes/5…

Our latest webinar is available on demand! 🔍 Key topics: - 3D in vitro modeling of nerve damage by MTIs. - Investigating ADC toxicity. - Partnering with MIMETAS for better drug discovery. Watch now: bit.ly/4byG27f #DrugDiscovery #PeripheralNeuropathy #ToxicityResearch

Watch our latest webinar, "Modeling ADC- and Chemotherapy-Induced Peripheral Neuropathy-on-a-Chip," where we cover topics such as 3D in vitro modeling of nerve damage by MTIs, Investigating ADC toxicity & Partnering with MIMETAS for better drug discovery. bit.ly/4byG27f

Want the latest on 3D tissue models, product launches, and new publications? 📩 Subscribe to our newsletter! You'll get: 🔬 Latest research 📚 New publications 🛠️ Product/service news 📅 Event invites Subscribe now: bit.ly/3yfQaEe #3DTissueModels #Innovation #Biotech

Check out our new app note! Snakebites are a major global health issue, affecting millions. We describe an assay to assess vascular toxicity from various snake venoms in the OrganoReady® Blood Vessel HUVEC 3-lane 64 using a multimode microplate reader. bit.ly/4cSTWCN

Read this paper on a multicellular 3D BBB-on-a-chip model that provides insights into barrier disruption, inflammation, and T cell migration under neuroinflammatory conditions. A significant step in understanding and treating neurological disorders. 🔗frontiersin.org/journals/molec…

Check out our new poster on the Bronchus-on-a-Chip (BoC) Platform for studying inflammatory airway diseases! This 3D model replicates the bronchus, allowing accurate investigations of airway remodeling and mucus hypersecretion. Download it here: bit.ly/4cfQgKe

Read Takeda's paper on a novel platelet aggregation assay developed in the OrganoPlate® platform, simulating in vivo conditions to better predict drug-induced thrombocytopenia, enhancing drug safety. Read the publication: bit.ly/4dnbcAn

Today, we spotlight our Scientific Project Lead, Linda Gijzen! Her motto, "Niet lullen maar poetsen" ("Don’t talk, but work"), embodies the action-driven spirit of MIMETAS. Our team makes MIMETAS special, driving innovation and impact. Read her interview: bit.ly/3Mdmrz6

Explore 100+ peer-reviewed publications from our customers and scientists: from disease modeling to drug discovery, explore breakthrough research. 🔍 Filter by 15 organ/disease models, including cancer, brain, and liver. bit.ly/3WTRIfG

Despite the prevalence of neurological diseases, human-relevant models are limited. This article features a 3D Human BBB model to explore neuroinflammation, barrier disruption, and immune cell migration. A leap forward in CNS research and drug development! bit.ly/3AOMgDc

Have you read about the first large-scale phenotypic screen using organ-on-a-chip? Check out our whitepaper "High-throughput Phenotypic Screening with Organ-on-a-Chip: A Perfused 3D Microfluidic Angiogenesis Assay," to learn about MIMETAS's achievement. bit.ly/3AUJwUQ

MIMETAS, Roche , and Tübingen University publish a review on Microphysiological Systems (MPS) for drug toxicity testing. MPS offers human-relevant models to predict side effects from therapies like CAR-T, ADCs, and AAV-based gene therapies. Read it here: bit.ly/4e9vQDZ

We’re excited to announce the launch of the OrganoReady® Colon Organoid! As the first 3D ready-to-use solution derived from adult stem cells, this translatable model is designed to enhance gastrointestinal toxicity screening. Learn more: bit.ly/4dTVKMl #OrganoidModel

Join MIMETAS at #EUROTOX2024 in Copenhagen! Visit booth #21 (Sept 8-11) to explore 3D human tissue models & our new OrganoReady® Colon Organoid for GI toxicity research. 🎤 Catch Vincent van Duinen's talk today 16:00-18:00 on liver fibrosis screening. bit.ly/4dTVKMl

Are you in drug development looking for better compound screening models? Join us this Sept 24 to learn how the OrganoReady® Colon Organoid are revolutionizing intestinal toxicity screenings! Register: bit.ly/3zfCKZC #GutToxicity #GItoxicity #Drugscreening

Together with STEMCELL Technologies, we took a deep-dive into the world of drug discovery, exploring how stem cell-based models are impacting the current field and shaping its future. stemcell.com/stem-cell-base… #stemcells #3Dtissuemodels #drugdiscovery #microphysiologicalsystems